Fundraising Fox
Intervene Inc
Mountain View, US · Founded 2011 · Delaware corporation · 17 employees on LinkedIn · 4 known investors
Find your way into Intervene Inc
Sign up to find every way you can get introduced to Intervene Inc
- Your email: who you already know at Intervene Inc, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Intervene Inc team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.
Founders & leadership
Intervene Inc was founded in 2011 by Fletcher Wilson.
Board
Investors · 4
How we know: LaunchCapital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: RiverVest Venture Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$11.1M disclosed across 4 rounds · 2015–2023
▶$1.5MraisedMar 2023 · 6 investors · Other Health CareRule 506(b)
- Adam BermanDirector
- Jeffrey ElkinsExecutive Officer, Director
- Catherine L. MatthesExecutive Officer
- Ginger GlaserDirector
- Joe BillerDirector
- Jay SchmelterDirector
- Fletcher WilsonDirector
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedMar 2023 · 6 investors · Other Health CareRule 506(b)
- Ginger GlaserDirector
- Fletcher WilsonDirector
- Jay SchmelterDirector
- Adam BermanDirector
- Catherine L. MatthesExecutive Officer
- Joe BillerDirector
- Jeffrey ElkinsExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedJun 2017 · 17 investors · Other Health CareRule 506(b)
- Evan NgExecutive Officer
- Thomas FogartyDirector
- Mel SchatzDirector
- Jay SchmelterDirector
- Fletcher WilsonExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.2M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedMar 2015 · 52 investors · Other Health CareRule 506(b)
- Mel SchatzDirector
- Thomas FogartyDirector
- Fletcher WilsonExecutive Officer, Director
- Evan NgExecutive Officer
- Offering amount
- $7.2M
- Amount sold
- $5.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Intervene Inc.
Frequently asked questions
- What does Intervene Inc do?
- InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions. Its technology targets venous disease conditions such as postthrombotic syndrome that current therapies fail to address.
- Who founded Intervene Inc?
- Intervene Inc was founded by Fletcher Wilson in 2011.
- Who are Intervene Inc's investors?
- Intervene Inc's investors include LaunchCapital, RiverVest Venture Partners, Treo Ventures, Llc, Emergent Medical Partners, LLP.
- How much funding has Intervene Inc raised?
- Intervene Inc has disclosed $11.1M raised across 4 rounds.
- Where is Intervene Inc headquartered?
- Intervene Inc is headquartered in Mountain View, US.